Loading…
To extend the suspension of duty on Bayderm Bottom DLV-N.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
7d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2012 · third_quarter · Torts
HR 4639; asbestos litigation reform
Client expense: Not reported · Firm income: $30,000
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · second_quarter · Tariff (miscellaneous tariff bills)
Duty suspension regarding the following: 1) Product: Difenoconazole, House Bill: HR 4794; 2) Product: DCDNBTF Benzene, House Bill: HR 4803; 3) Product: 2-Chloro-6- Fluorobenzyl, House Bill: HR 4805; 4)Product: Flumetralin Technical, House BIll: HR 4802; 5) Cyprodinil Tech, House Bill: HR 4793; 6) Product: Trinexapac-Ethyl Tech, House Bill: HR 4801; 7) Product: Lamda-Cyhalothrin, House Bill: HR 4797; 8) Product: Thia-Difen-Flud-Mef, House Bill: HR 4796; 9) Product: Difenoconazole & Mefenoxem, House Bill: HR 4795; 10) Product: Mucochloric Acid, House Bill: HR 4798; 11) Methidathion Tech, House Bill: HR 4800; 12) 4-Chloro-3.5 Dinitrobenzotrifluoride, House Bill: HR 4804; 13) Wakil XL, House Bill: HR 4799; 14) Thiamethoxam Tech, House Bill: HR 4728; 15) Trifloxysulfuron-Sodium Tech, House Bill: HR 4730; 16) Triasulfuron Tech, House Bill: HR 4729; 17) Propiconazole Tech; 18) Paraquat Dechloride Tech, House Bill: HR 4642; 19) NOA 446510 Tech, House Bill: HR 4639; 20) IPN, House Bill: HR 4640; 21) Paclobutrazol 2SC, House Bill: HR 4643; 22) Paclobutrazol Tech, House Bill: HR 4638; 23) Brodifacoum Tech, House Bill: HR 4644; 24) Azoxystrobin Technical-benzeneacertic; 25) Fludioxinil Tech, House Bill: HR 4711; 26) Clodinafop Tech; House Bill: HR 4712; 27) Pinoxaden Tech; House Bill: HR 4715; 28) Azoxystrobin Technical; House Bill: HR 4792; 29) Mefenoxam Tech; House Bill: HR 4714; 30) TEHP; 31) Cloquintocet Tech; House BIll: HR 4709; 32) Prosulfuron Tech; House Bill: HR 4717; 33) Avermectin B; House Bill: HR 4708; 34) Cyproconazole Tech, House Bill: HR 4710; 35) Pymetrozine Tech, House Bill: HR 4718; 36) Primisulfuron; 37) Mesotrione Tech, House Bill: HR 4366; 38) s-Metolachlor; 39) DEMBB -Bromo, House Bill: HR 4365; 40) Promdiamine Tech, House Bill: HR 4572; 41) Chloroacetone, House Bill: HR 4641; 42) Ortho-Nitro-Phenol 2-Nitrophenol, House Bill: HR 4573.
Client expense: $210,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, State, Dept of (DOS), U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
2011 · first_quarter · Tariff (miscellaneous tariff bills)
Duty suspension regarding the following: 1) Product: Difenoconazole, House Bill: HR 4794; 2) Product: DCDNBTF Benzene, House Bill: HR 4803; 3) Product: 2-Chloro-6- Fluorobenzyl, House Bill: HR 4805; 4)Product: Flumetralin Technical, House BIll: HR 4802; 5) Cyprodinil Tech, House Bill: HR 4793; 6) Product: Trinexapac-Ethyl Tech, House Bill: HR 4801; 7) Product: Lamda-Cyhalothrin, House Bill: HR 4797; 8) Product: Thia-Difen-Flud-Mef, House Bill: HR 4796; 9) Product: Difenoconazole & Mefenoxem, House Bill: HR 4795; 10) Product: Mucochloric Acid, House Bill: HR 4798; 11) Methidathion Tech, House Bill: HR 4800; 12) 4-Chloro-3.5 Dinitrobenzotrifluoride, House Bill: HR 4804; 13) Wakil XL, House Bill: HR 4799; 14) Thiamethoxam Tech, House Bill: HR 4728; 15) Trifloxysulfuron-Sodium Tech, House Bill: HR 4730; 16) Triasulfuron Tech, House Bill: HR 4729; 17) Propiconazole Tech; 18) Paraquat Dechloride Tech, House Bill: HR 4642; 19) NOA 446510 Tech, House Bill: HR 4639; 20) IPN, House Bill: HR 4640; 21) Paclobutrazol 2SC, House Bill: HR 4643; 22) Paclobutrazol Tech, House Bill: HR 4638; 23) Brodifacoum Tech, House Bill: HR 4644; 24) Azoxystrobin Technical-benzeneacertic; 25) Fludioxinil Tech, House Bill: HR 4711; 26) Clodinafop Tech; House Bill: HR 4712; 27) Pinoxaden Tech; House Bill: HR 4715; 28) Azoxystrobin Technical; House Bill: HR 4792; 29) Mefenoxam Tech; House Bill: HR 4714; 30) TEHP; 31) Cloquintocet Tech; House BIll: HR 4709; 32) Prosulfuron Tech; House Bill: HR 4717; 33) Avermectin B; House Bill: HR 4708; 34) Cyproconazole Tech, House Bill: HR 4710; 35) Pymetrozine Tech, House Bill: HR 4718; 36) Primisulfuron; 37) Mesotrione Tech, House Bill: HR 4366; 38) s-Metolachlor; 39) DEMBB -Bromo, House Bill: HR 4365; 40) Promdiamine Tech, House Bill: HR 4572; 41) Chloroacetone, House Bill: HR 4641; 42) Ortho-Nitro-Phenol 2-Nitrophenol, House Bill: HR 4573.
Client expense: $220,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, State, Dept of (DOS), U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
2011 · second_quarter · Tariff (miscellaneous tariff bills)
Duty suspension regarding the following: 1) Product: Difenoconazole, House Bill: HR 4794; 2) Product: DCDNBTF Benzene, House Bill: HR 4803; 3) Product: 2-Chloro-6- Fluorobenzyl, House Bill: HR 4805; 4)Product: Flumetralin Technical, House BIll: HR 4802; 5) Cyprodinil Tech, House Bill: HR 4793; 6) Product: Trinexapac-Ethyl Tech, House Bill: HR 4801; 7) Product: Lamda-Cyhalothrin, House Bill: HR 4797; 8) Product: Thia-Difen-Flud-Mef, House Bill: HR 4796; 9) Product: Difenoconazole & Mefenoxem, House Bill: HR 4795; 10) Product: Mucochloric Acid, House Bill: HR 4798; 11) Methidathion Tech, House Bill: HR 4800; 12) 4-Chloro-3.5 Dinitrobenzotrifluoride, House Bill: HR 4804; 13) Wakil XL, House Bill: HR 4799; 14) Thiamethoxam Tech, House Bill: HR 4728; 15) Trifloxysulfuron-Sodium Tech, House Bill: HR 4730; 16) Triasulfuron Tech, House Bill: HR 4729; 17) Propiconazole Tech; 18) Paraquat Dechloride Tech, House Bill: HR 4642; 19) NOA 446510 Tech, House Bill: HR 4639; 20) IPN, House Bill: HR 4640; 21) Paclobutrazol 2SC, House Bill: HR 4643; 22) Paclobutrazol Tech, House Bill: HR 4638; 23) Brodifacoum Tech, House Bill: HR 4644; 24) Azoxystrobin Technical-benzeneacertic; 25) Fludioxinil Tech, House Bill: HR 4711; 26) Clodinafop Tech; House Bill: HR 4712; 27) Pinoxaden Tech; House Bill: HR 4715; 28) Azoxystrobin Technical; House Bill: HR 4792; 29) Mefenoxam Tech; House Bill: HR 4714; 30) TEHP; 31) Cloquintocet Tech; House BIll: HR 4709; 32) Prosulfuron Tech; House Bill: HR 4717; 33) Avermectin B; House Bill: HR 4708; 34) Cyproconazole Tech, House Bill: HR 4710; 35) Pymetrozine Tech, House Bill: HR 4718; 36) Primisulfuron; 37) Mesotrione Tech, House Bill: HR 4366; 38) s-Metolachlor; 39) DEMBB -Bromo, House Bill: HR 4365; 40) Promdiamine Tech, House Bill: HR 4572; 41) Chloroacetone, House Bill: HR 4641; 42) Ortho-Nitro-Phenol 2-Nitrophenol, House Bill: HR 4573.
Client expense: $110,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, State, Dept of (DOS), U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
2011 · first_quarter · Tariff (miscellaneous tariff bills)
Duty suspension regarding the following: 1) Product: Difenoconazole, House Bill: HR 4794; 2) Product: DCDNBTF Benzene, House Bill: HR 4803; 3) Product: 2-Chloro-6- Fluorobenzyl, House Bill: HR 4805; 4)Product: Flumetralin Technical, House BIll: HR 4802; 5) Cyprodinil Tech, House Bill: HR 4793; 6) Product: Trinexapac-Ethyl Tech, House Bill: HR 4801; 7) Product: Lamda-Cyhalothrin, House Bill: HR 4797; 8) Product: Thia-Difen-Flud-Mef, House Bill: HR 4796; 9) Product: Difenoconazole & Mefenoxem, House Bill: HR 4795; 10) Product: Mucochloric Acid, House Bill: HR 4798; 11) Methidathion Tech, House Bill: HR 4800; 12) 4-Chloro-3.5 Dinitrobenzotrifluoride, House Bill: HR 4804; 13) Wakil XL, House Bill: HR 4799; 14) Thiamethoxam Tech, House Bill: HR 4728; 15) Trifloxysulfuron-Sodium Tech, House Bill: HR 4730; 16) Triasulfuron Tech, House Bill: HR 4729; 17) Propiconazole Tech; 18) Paraquat Dechloride Tech, House Bill: HR 4642; 19) NOA 446510 Tech, House Bill: HR 4639; 20) IPN, House Bill: HR 4640; 21) Paclobutrazol 2SC, House Bill: HR 4643; 22) Paclobutrazol Tech, House Bill: HR 4638; 23) Brodifacoum Tech, House Bill: HR 4644; 24) Azoxystrobin Technical-benzeneacertic; 25) Fludioxinil Tech, House Bill: HR 4711; 26) Clodinafop Tech; House Bill: HR 4712; 27) Pinoxaden Tech; House Bill: HR 4715; 28) Azoxystrobin Technical; House Bill: HR 4792; 29) Mefenoxam Tech; House Bill: HR 4714; 30) TEHP; 31) Cloquintocet Tech; House BIll: HR 4709; 32) Prosulfuron Tech; House Bill: HR 4717; 33) Avermectin B; House Bill: HR 4708; 34) Cyproconazole Tech, House Bill: HR 4710; 35) Pymetrozine Tech, House Bill: HR 4718; 36) Primisulfuron; 37) Mesotrione Tech, House Bill: HR 4366; 38) s-Metolachlor; 39) DEMBB -Bromo, House Bill: HR 4365; 40) Promdiamine Tech, House Bill: HR 4572; 41) Chloroacetone, House Bill: HR 4641; 42) Ortho-Nitro-Phenol 2-Nitrophenol, House Bill: HR 4573.
Client expense: $140,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, State, Dept of (DOS), U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office